EGFR and cancer: The cancer-associated fibroblasts (CAFs) have been found to secrete hepatocyte growth factor (HGF), thereby instigating resistance to pharmacological interventions targeting tyrosine kinases and the epidermal growth factor receptor (EGFR) [28].